Evidence map›Paper›PMID 38900572›Full record

ArticleThe Journal of clinical investigation2024

Androgen aggravates aortic aneurysms via suppression of PD-1 in mice.

Xufang Mu, Shu Liu, Zhuoran Wang, Kai Jiang, Tim McClintock, Arnold J Stromberg, Alejandro V Tezanos, Eugene S Lee, John A Curci, Ming C Gong and 1 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Emerging Mechanisms of Abdominal Aortic Aneurysm.Current atherosclerosis reports · 2026
    Review
  3. Article
  4. Review
  5. Unleashing PD-1: a duel of immunity in aortic aneurysm formation.The Journal of clinical investigation · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Xufang MuDepartments of Pharmacology and Nutritional Sciences.
Shu LiuPhysiology, and.
Zhuoran WangDepartments of Pharmacology and Nutritional Sciences.
Kai JiangPhysiology, and.
Tim McClintockPhysiology, and.
Arnold J StrombergStatistics, University of Kentucky, Lexington, Kentucky, USA.
Alejandro V TezanosStatistics, University of Kentucky, Lexington, Kentucky, USA.
Eugene S LeeDepartment of Research, Sacramento Veterans Affairs Medical Center, Mather, California, USA.
John A CurciDepartment of Vascular Surgery, Vanderbilt University, Nashville, Tennessee, USA.
Ming C GongPhysiology, and.
Zhenheng GuoDepartments of Pharmacology and Nutritional Sciences.

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
Pilot Projects ProgramP30GM127211 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2018 to 2022
$5.7M
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetesR01HL164398 · NHLBI · UNIVERSITY OF KENTUCKY · PI GONG, MING C, GUO, ZHENHENG · 2022 to 2025
$2.8M
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosisR01HL166225 · NHLBI · UNIVERSITY OF KENTUCKY · PI MING C GONG, Zhenheng Guo · 2023 to 2026
$2.6M
A novel mechanism by which smooth muscle BMAL1 regulates IL-6 and sexual dimorphism of abdominal aortic aneurysmR01HL142973 · NHLBI · UNIVERSITY OF KENTUCKY · PI GONG, MING C, GUO, ZHENHENG · 2018 to 2021
$2.6M
Targeting timing of food intake as a novel strategy against disruption of blood pressure circadian rhythm in diabetesR01HL141103 · NHLBI · UNIVERSITY OF KENTUCKY · PI GONG, MING C, GUO, ZHENHENG · 2019 to 2022
$2.5M
In vivo patterns of receptor activation by odorantsR01DC014468 · NIDCD · UNIVERSITY OF KENTUCKY · PI MCCLINTOCK, TIMOTHY S · 2016 to 2020
$2.4M
Targeting Endothelial Cell Mineralocorticoid Receptor Against Aortic Aneurysm in FemalesR01HL163589 · NHLBI · UNIVERSITY OF KENTUCKY · PI MING C GONG, Zhenheng Guo · 2024 to 2026
$2.2M
Mineralocorticoid receptor and abdominal aortic aneurysmR01HL125228 · NHLBI · UNIVERSITY OF KENTUCKY · PI GONG, MING C, GUO, ZHENHENG · 2015 to 2018
$2.1M
Odorant Receptor Expression and Sensitivity to OdorantsK18DC014050 · NIDCD · UNIVERSITY OF KENTUCKY · PI MCCLINTOCK, TIMOTHY S · 2014 to 2015
$209k
Role of RhoA in small AAA growthI01CX001683 · VA · VA NORTHERN CALIFORNIA HEALTH CARE SYS · PI GUO, ZHENHENG, LEE, EUGENE SANGKEU · 2019 to 2023
–
CSRD VA I01 CX001683NCI NIH HHS P30 CA177558NHLBI NIH HHS R01 HL125228NHLBI NIH HHS R01 HL141103NHLBI NIH HHS R01 HL142973NHLBI NIH HHS R01 HL163589NHLBI NIH HHS R01 HL164398NHLBI NIH HHS R01 HL166225NIDCD NIH HHS K18 DC014050NIDCD NIH HHS R01 DC014468NIGMS NIH HHS P30 GM127211
6 · The paper itself

Abstract

Androgen has long been recognized for its pivotal role in the sexual dimorphism of cardiovascular diseases, including aortic aneurysms (AAs), a devastating vascular disease with a higher prevalence and fatality rate in men than in women. However, the mechanism by which androgen mediates AAs is largely unknown. Here, we found that male, not female, mice developed AAs when exposed to aldosterone and high salt (Aldo-salt). We revealed that androgen and androgen receptors (ARs) were crucial for this sexually dimorphic response to Aldo-salt. We identified programmed cell death protein 1 (PD-1), an immune checkpoint, as a key link between androgen and AAs. Furthermore, we demonstrated that administration of anti-PD-1 Ab and adoptive PD-1-deficient T cell transfer reinstated Aldo-salt-induced AAs in orchiectomized mice and that genetic deletion of PD-1 exacerbated AAs induced by a high-fat diet and angiotensin II (Ang II) in nonorchiectomized mice. Mechanistically, we discovered that the AR bound to the PD-1 promoter to suppress the expression of PD-1 in the spleen. Thus, our study unveils a mechanism by which androgen aggravates AAs by suppressing PD-1 expression in T cells. Moreover, our study suggests that some patients with cancer might benefit from screenings for AAs during immune checkpoint therapy.

Indexed as

AndrogensAortic AneurysmProgrammed Cell Death 1 ReceptorReceptors, AndrogenAldosteroneAngiotensin IIAnimalsFemaleHumansMaleMiceMice, KnockoutAldosteroneAndrogensAngiotensin IIAR protein, mousePdcd1 protein, mouseProgrammed Cell Death 1 ReceptorReceptors, AndrogenInflammationSex hormonesT cellsVascular biologyVasculitis

Identifiers

PMID38900572
PMCPMC11290977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.